$Daxor(DXR.US)$ Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide Daxor (Nasdaq: DXR) announced the expansion of its blood volume analysis (BVA) technology, including the launch of new BVA programs and the increased adoption of its ezBVA Lab service. This CLIA-certified facility provides next-day blood volume analysis results on-demand. Recent expansions include a regional referral center for Northeast Arkansas and Southeast Missouri...
Daxor股票討論區
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
Daxor (Nasdaq: DXR) announced the expansion of its blood volume analysis (BVA) technology, including the launch of new BVA programs and the increased adoption of its ezBVA Lab service. This CLIA-certified facility provides next-day blood volume analysis results on-demand. Recent expansions include a regional referral center for Northeast Arkansas and Southeast Missouri...
新聞
新研究證明達克索血量(BVA-100TM)診斷在門診心衰竭患者的臨床好處以測量擁塞
達克索(納斯達克:DXR)宣布兩項新研究,驗證血量分析(BVA)在門診心力衰竭患者的臨床好處。這些研究強調代劑量與實際血量之間缺乏相關性,並強調準確體積測量的重要性。數據顯示在...
我們正在尋求社區對該股票在未來一到兩個月內潛在變動的見解。你預計它會上升還是下降?
如果您有任何可能影響該股票方向的堅實想法,內幕信息或新聞,請在下面的評論部分中分享。您的輸入非常重視!
感謝您的參與。
$Daxor(DXR.US)$
$Top Ships(TOPS.US)$
$CHF Solutions Inc(CHFS.US)$
$Vuzix(VUZI.US)$
$Vislink技術(VISL.US)$
$格陵蘭科技(GTEC.US)$
$Trevi Therapeutics(TRVI.US)$
$烏龍製藥(URGN.US)$
暫無評論